Deka Bank Deutsche Girozentrale Adaptive Biotechnologies Corp Transaction History

Deka Bank Deutsche Girozentrale

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 Apr 28, 2022	BUY	$10.12 - $28.9 $54,647 - $156,060	5,400 Added 9.96%	59,600 $827,000
Q4 2021 Feb 02, 2022	BUY	$25.17 - $36.85 $281,904 - $412,720	11,200 Added 26.05%	54,200 $1.41 Million
Q4 2020 Mar 12, 2021	BUY	$45.01 - $65.47 $130,529 - $189,863	2,900 Added 7.23%	43,000 $2.54 Million
Q3 2020 Oct 29, 2020	BUY	$35.79 - $48.81 $1.44 Million - $1.96 Million	40,100 New	40,100 $1.9 Million

202

146M

68.8K

42.5K

Ticker ADPT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 142,872,992
Market Cap $849M
Description
Adaptive Biotechnologies Corporation, a commercial-stage company, develops an immune medicine platform for the diagnosis and treatment of various diseases. The company offers immunoSEQ, a platform and core immunosequencing product that is used to answer translational research questions, as well as to discover new prognostic and diagnostic signal...

Get notified when there are updates to the investment portfolio of Deka Bank Deutsche Girozentrale, based on Form 13F filings with the SEC.

Stay updated on Deka Bank Deutsche Girozentrale with notifications on news.